KODIAK SCIENCES INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
KODIAK SCIENCES INC. (KOD) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$48.28 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-31
- KODIAK SCIENCES INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$48.28M.
- KODIAK SCIENCES INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$37.00M.
- KODIAK SCIENCES INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was -$54.69M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month |
|---|---|
| 2025-12-31 | -$48.28M 10-K · filed 2026-03-31 |
| 2024-12-31 | -$37.00M 10-K · filed 2026-03-31 |
| 2023-12-31 | -$54.69M 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |